Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1954 2
1956 2
1961 1
1963 5
1964 1
1965 3
1966 7
1967 8
1968 14
1969 12
1970 10
1971 23
1972 18
1973 11
1974 14
1975 9
1976 6
1977 14
1978 20
1979 17
1980 31
1981 30
1982 33
1983 35
1984 37
1985 40
1986 24
1987 33
1988 37
1989 55
1990 35
1991 47
1992 57
1993 51
1994 35
1995 31
1996 43
1997 35
1998 50
1999 45
2000 41
2001 59
2002 67
2003 73
2004 59
2005 67
2006 59
2007 66
2008 66
2009 80
2010 64
2011 80
2012 104
2013 94
2014 110
2015 116
2016 108
2017 122
2018 169
2019 171
2020 187
2021 220
2022 202
2023 185
2024 60

Text availability

Article attribute

Article type

Publication date

Search Results

3,290 results

Results by year

Filters applied: . Clear all
Page 1
The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.
Saito S, Ando K, Sakamoto S, Xu M, Yamada Y, Rii J, Kanaoka S, Wei J, Zhao X, Pae S, Kanesaka M, Goto Y, Sazuka T, Imamura Y, Reien Y, Hamaguchi-Suzuki N, Saito S, Hirayama Y, Hashimoto H, Kanai Y, Ichikawa T, Anzai N. Saito S, et al. Among authors: sakamoto s. Cancer Sci. 2024 Apr 24. doi: 10.1111/cas.16191. Online ahead of print. Cancer Sci. 2024. PMID: 38655663 Free article.
Two recurrent types of IGH::5' BCL2 breakpoints representing cytogenetic ins(14;18)(q32;q21q21) and t(14;18)(q32;q21), mediated by the VDJ and class switch recombination processes, respectively.
Maekawa F, Hayashida M, Takeoka K, Fukutsuka K, Nakagawa M, Akasaka T, Sakamoto S, Sumiyoshi S, Kobashi Y, Ohno H. Maekawa F, et al. Among authors: sakamoto s. Leuk Lymphoma. 2024 Apr 12:1-10. doi: 10.1080/10428194.2024.2341333. Online ahead of print. Leuk Lymphoma. 2024. PMID: 38608254
3,290 results